LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription
LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription
About this item
Full title
Author / Creator
Lin, Zhongjie , Xia, Shunjie , Liang, Yuelong , Ji, Lin , Pan, Yu , Jiang, Shi , Wan, Zhe , Tao, Liye , Chen, Jiang , Lin, Chengping , Liang, Xiao , Xu, Junjie and Cai, Xiujun
Publisher
Australia: Ivyspring International Publisher Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Australia: Ivyspring International Publisher Pty Ltd
Subjects
More information
Scope and Contents
Contents
Sorafenib resistance is a major obstacle to the treatment of advanced hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) are multifunctional regulators of gene expression with profound impact for human disease. Therefore, better understanding of the biological mechanisms of abnormally expressed miRNAs is critical to discovering novel, promising the...
Alternative Titles
Full title
LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7392029
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7392029
Other Identifiers
ISSN
1838-7640
E-ISSN
1838-7640
DOI
10.7150/thno.45158
